Valeant Pharma eyes NC office

Raleigh, North Carolina's News & Observer reports that California-based Valeant Pharmaceuticals is in discussions for an office building in Durham. The developer already has 25 employees in the Research Triangle Park area, but that number could grow significantly if the company plans to boost its presence there. Article

Suggested Articles

Data from a 10,000-patient trial showed that people with osteoarthritis taking Novartis' Ilaris had 40% to 47% lower rates of joint replacements.

Immunic's lead asset beat placebo at reducing damage to myelin, which protects nerve fibers, in patients with relapsing multiple sclerosis.

The appointment sees Kobayashi switch from developing Dermira’s anti-IL-13 drug to advancing Aslan’s would-be rival.